By the time an organization decides fentanyl screening may be appropriate, the next step is practical: How do you evaluate the panel itself?
The first place to start is simple. Confirm whether fentanyl is actually included in the panel configuration. Not every 10-panel, 12-panel, or expanded test automatically includes fentanyl, so it is important to review the product specifications rather than rely on the panel name alone.
Next, consider the testing format. Urine cups, oral fluid devices, and dip cards may all support different workflows depending on your program’s needs. The right choice often comes down to collection setting, turnaround expectations, and how the results will be documented.
It is also worth looking at whether the test includes additional features that matter to your organization, such as adulterants, temperature strips, or broader panel coverage beyond fentanyl alone. For some programs, a fentanyl-inclusive panel may be one part of a larger opioid or expanded drug screening strategy.
Finally, think about fit. The best panel is not always the broadest one. It is the one that aligns with your workplace environment, compliance goals, and overall testing objectives.
Fact Friday takeaway:
Evaluating a fentanyl drug testing panel starts with understanding what it actually includes, how it fits your workflow, and whether it supports your program goals.
Using a credible resource for drug screening supplies helps support consistency and reliability across your program.
